查詢結果分析
來源資料
相關文獻
- An Early Predictor of the Outcome of Patients with Ventilator-associated Pneumonia
- Ventilator-Associated Pneumonia with Circuit Changes Every 2 Days Versus Every Week
- The Incidence of Ventilator-Associated Pneumonia in Weekly and Bi-Weekly Ventilator Circuit Changes
- 口腔抽吸在降低呼吸器相關肺炎之成效
- 降低某兒科加護病房開心術後呼吸器相關性肺炎感染密度專案
- 呼吸器相關性肺炎(Ventilator-Associated Pneumonia)的臨床處置與爭議
- 呼吸器相關性肺炎
- 某區域教學醫院加護病房發生呼吸器相關性肺炎之分析研究
- 呼吸器相關事件(VAE)自動化即時監測系統:成功實證報告
- 聲門下分泌物引流對呼吸器相關性肺炎效果之評價
頁籤選單縮合
題名 | An Early Predictor of the Outcome of Patients with Ventilator-associated Pneumonia=“呼吸器相關性肺炎”預後的早期預測指標 |
---|---|
作者姓名(中文) | 黃國棟; 曾嘉成; 方文豐; 林孟志; | 書刊名 | 長庚醫誌 |
卷期 | 33:3 2010.05-06[民99.05-06] |
頁次 | 頁274-282 |
分類號 | 415.463 |
關鍵詞 | 呼吸器相關性肺炎; 臨床肺部感染分數; APACHE II分數; Ventilator-associated pneumonia; VAP; Clinical pulmonary infection score; CPIS; Acute physiological assessment and chronic health evaluation II score; APACHE II score; |
語文 | 英文(English) |
中文摘要 | 2004 1 2006 6 ( II ) 838 42 28 23.8%.5% 50% APACHE II 27 APACHE II ( 27 ) |
英文摘要 | Background: Ventilator-associated pneumonia (VAP) contributes to high mortality, prolonged intensive care unit (ICU) stay and increased costs of health care. Reports of early predictors of death in patients with VAP are rare. Our study was designed to determine early predictors of poor outcome in patients with VAP. Methods: A total 838 patients with nosocomial lower respiratory tract infection in a tertiary medical center from January, 2004 to June, 2006 were retrospectively reviewed. Forty-two patients had VAP and were enrolled in the study. The age, sex, underlying diseases, including hypertension, diabetes mellitus, chronic obstructive pulmonary disease, end-stage renal disease, congestive heart failure/coronary artery disease, and collagen vascular disease, diagnosis at admission, Acute Physiological Assessment and Chronic Health Evaluation II score (APACHE II score), Clinical Pulmonary Infection Score (CPIS), time between intubation and ICU admission, time between intubation and development of VAP, risk factors for multi-drug resistant pathogens, time to adequate therapy, initial antibiotics regimen, bacterial cultures, mortality rate from VAP, 28-day mortality rate and in-hospital mortality rate were compared between the mortality group and non-mortality group. Results: The VAP, 28-day and in-hospital mortality rates were 23.8% (10/42), 40.5% (17/42) and 50% (21/42), respectively. The APACHE II score (p = 0.002) and CPIS (p = 0.048) at the onset of VAP, inadequate initial antibiotics treatment (p = 0.007) and concomitant bacteremia (p = 0.008) were the only parameters which were significantly different between groups. The independent risk factors for VAP mortality in multivariable analysis were the APACHE II score at the onset of VAP (p = 0.018), inadequate initial antibiotics treatment (p = 0.032) and concomitant bacteremia (p = 0.034). An APACHE II score > 27 at VAP onset was an independent and early predictor of the mortality. (ROC AUC: 0.841; Sensitivity: 70%; Specificity: 90.6%; p = 0.001). Conclusion: A high APACHE II score ( > 27) at VAP onset was an independent and early predictor of mortality due to VAP. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。